img

Global Axillary Hyperhidrosis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Axillary Hyperhidrosis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Axillary Hyperhidrosis Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Axillary Hyperhidrosis Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Axillary Hyperhidrosis Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Axillary Hyperhidrosis Drug key manufacturers include Allergan Plc, Brickell Biotech Inc, Dermira Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, GlaxoSmithKline Plc and TheraVida Inc, etc. Allergan Plc, Brickell Biotech Inc, Dermira Inc are top 3 players and held % sales share in total in 2022.
Axillary Hyperhidrosis Drug can be divided into Botulinum ToxinA, Glycopyrrolate, Glycopyrronium Tosylate and Others, etc. Botulinum ToxinA is the mainstream product in the market, accounting for % sales share globally in 2022.
Axillary Hyperhidrosis Drug is widely used in various fields, such as Clinic, Hospital and Home Care,, etc. Clinic provides greatest supports to the Axillary Hyperhidrosis Drug industry development. In 2022, global % sales of Axillary Hyperhidrosis Drug went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Axillary Hyperhidrosis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan Plc
Brickell Biotech Inc
Dermira Inc
Dr. August Wolff GmbH & Co KG Arzneimittle
GlaxoSmithKline Plc
TheraVida Inc
Segment by Type
Botulinum ToxinA
Glycopyrrolate
Glycopyrronium Tosylate
Others

Segment by Application


Clinic
Hospital
Home Care

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Axillary Hyperhidrosis Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Axillary Hyperhidrosis Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Axillary Hyperhidrosis Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Axillary Hyperhidrosis Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Axillary Hyperhidrosis Drug introduction, etc. Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Axillary Hyperhidrosis Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Axillary Hyperhidrosis Drug Market Overview
1.1 Axillary Hyperhidrosis Drug Product Overview
1.2 Axillary Hyperhidrosis Drug Market Segment by Type
1.2.1 Botulinum ToxinA
1.2.2 Glycopyrrolate
1.2.3 Glycopyrronium Tosylate
1.2.4 Others
1.3 Global Axillary Hyperhidrosis Drug Market Size by Type
1.3.1 Global Axillary Hyperhidrosis Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Axillary Hyperhidrosis Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Axillary Hyperhidrosis Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Axillary Hyperhidrosis Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Axillary Hyperhidrosis Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Axillary Hyperhidrosis Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Axillary Hyperhidrosis Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Axillary Hyperhidrosis Drug Sales Breakdown by Type (2018-2024)
2 Global Axillary Hyperhidrosis Drug Market Competition by Company
2.1 Global Top Players by Axillary Hyperhidrosis Drug Sales (2018-2024)
2.2 Global Top Players by Axillary Hyperhidrosis Drug Revenue (2018-2024)
2.3 Global Top Players by Axillary Hyperhidrosis Drug Price (2018-2024)
2.4 Global Top Manufacturers Axillary Hyperhidrosis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Axillary Hyperhidrosis Drug Market Competitive Situation and Trends
2.5.1 Axillary Hyperhidrosis Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Axillary Hyperhidrosis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Axillary Hyperhidrosis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Axillary Hyperhidrosis Drug Market
2.8 Key Manufacturers Axillary Hyperhidrosis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Axillary Hyperhidrosis Drug Status and Outlook by Region
3.1 Global Axillary Hyperhidrosis Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Axillary Hyperhidrosis Drug Historic Market Size by Region
3.2.1 Global Axillary Hyperhidrosis Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Axillary Hyperhidrosis Drug Sales in Value by Region (2018-2024)
3.2.3 Global Axillary Hyperhidrosis Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Axillary Hyperhidrosis Drug Forecasted Market Size by Region
3.3.1 Global Axillary Hyperhidrosis Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Axillary Hyperhidrosis Drug Sales in Value by Region (2024-2034)
3.3.3 Global Axillary Hyperhidrosis Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Axillary Hyperhidrosis Drug by Application
4.1 Axillary Hyperhidrosis Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Home Care
4.2 Global Axillary Hyperhidrosis Drug Market Size by Application
4.2.1 Global Axillary Hyperhidrosis Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Axillary Hyperhidrosis Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Axillary Hyperhidrosis Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Axillary Hyperhidrosis Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Axillary Hyperhidrosis Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Axillary Hyperhidrosis Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Axillary Hyperhidrosis Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Axillary Hyperhidrosis Drug Sales Breakdown by Application (2018-2024)
5 North America Axillary Hyperhidrosis Drug by Country
5.1 North America Axillary Hyperhidrosis Drug Historic Market Size by Country
5.1.1 North America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Axillary Hyperhidrosis Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Axillary Hyperhidrosis Drug Sales in Value by Country (2018-2024)
5.2 North America Axillary Hyperhidrosis Drug Forecasted Market Size by Country
5.2.1 North America Axillary Hyperhidrosis Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Axillary Hyperhidrosis Drug Sales in Value by Country (2024-2034)
6 Europe Axillary Hyperhidrosis Drug by Country
6.1 Europe Axillary Hyperhidrosis Drug Historic Market Size by Country
6.1.1 Europe Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Axillary Hyperhidrosis Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Axillary Hyperhidrosis Drug Sales in Value by Country (2018-2024)
6.2 Europe Axillary Hyperhidrosis Drug Forecasted Market Size by Country
6.2.1 Europe Axillary Hyperhidrosis Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Axillary Hyperhidrosis Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Axillary Hyperhidrosis Drug by Region
7.1 Asia-Pacific Axillary Hyperhidrosis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Axillary Hyperhidrosis Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Axillary Hyperhidrosis Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Axillary Hyperhidrosis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Axillary Hyperhidrosis Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Axillary Hyperhidrosis Drug Sales in Value by Region (2024-2034)
8 Latin America Axillary Hyperhidrosis Drug by Country
8.1 Latin America Axillary Hyperhidrosis Drug Historic Market Size by Country
8.1.1 Latin America Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Axillary Hyperhidrosis Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Axillary Hyperhidrosis Drug Sales in Value by Country (2018-2024)
8.2 Latin America Axillary Hyperhidrosis Drug Forecasted Market Size by Country
8.2.1 Latin America Axillary Hyperhidrosis Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Axillary Hyperhidrosis Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Axillary Hyperhidrosis Drug by Country
9.1 Middle East and Africa Axillary Hyperhidrosis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Axillary Hyperhidrosis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Axillary Hyperhidrosis Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Axillary Hyperhidrosis Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Axillary Hyperhidrosis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Axillary Hyperhidrosis Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Allergan Plc
10.1.1 Allergan Plc Company Information
10.1.2 Allergan Plc Introduction and Business Overview
10.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Allergan Plc Axillary Hyperhidrosis Drug Products Offered
10.1.5 Allergan Plc Recent Development
10.2 Brickell Biotech Inc
10.2.1 Brickell Biotech Inc Company Information
10.2.2 Brickell Biotech Inc Introduction and Business Overview
10.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Products Offered
10.2.5 Brickell Biotech Inc Recent Development
10.3 Dermira Inc
10.3.1 Dermira Inc Company Information
10.3.2 Dermira Inc Introduction and Business Overview
10.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Dermira Inc Axillary Hyperhidrosis Drug Products Offered
10.3.5 Dermira Inc Recent Development
10.4 Dr. August Wolff GmbH & Co KG Arzneimittle
10.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
10.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Introduction and Business Overview
10.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Products Offered
10.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Development
10.5 GlaxoSmithKline Plc
10.5.1 GlaxoSmithKline Plc Company Information
10.5.2 GlaxoSmithKline Plc Introduction and Business Overview
10.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Products Offered
10.5.5 GlaxoSmithKline Plc Recent Development
10.6 TheraVida Inc
10.6.1 TheraVida Inc Company Information
10.6.2 TheraVida Inc Introduction and Business Overview
10.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 TheraVida Inc Axillary Hyperhidrosis Drug Products Offered
10.6.5 TheraVida Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Axillary Hyperhidrosis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Axillary Hyperhidrosis Drug Industrial Chain Analysis
11.4 Axillary Hyperhidrosis Drug Market Dynamics
11.4.1 Axillary Hyperhidrosis Drug Industry Trends
11.4.2 Axillary Hyperhidrosis Drug Market Drivers
11.4.3 Axillary Hyperhidrosis Drug Market Challenges
11.4.4 Axillary Hyperhidrosis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Axillary Hyperhidrosis Drug Distributors
12.3 Axillary Hyperhidrosis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Botulinum ToxinA
Table 2. Major Company of Glycopyrrolate
Table 3. Major Company of Glycopyrronium Tosylate
Table 4. Major Company of Others
Table 5. Global Axillary Hyperhidrosis Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Axillary Hyperhidrosis Drug Market Share in Value by Type (2018-2024)
Table 10. Global Axillary Hyperhidrosis Drug Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Axillary Hyperhidrosis Drug Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Axillary Hyperhidrosis Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Axillary Hyperhidrosis Drug Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Axillary Hyperhidrosis Drug Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Axillary Hyperhidrosis Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Axillary Hyperhidrosis Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Axillary Hyperhidrosis Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Axillary Hyperhidrosis Drug Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Axillary Hyperhidrosis Drug Sales Share by Company (2018-2024)
Table 28. Global Axillary Hyperhidrosis Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Axillary Hyperhidrosis Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Axillary Hyperhidrosis Drug Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Axillary Hyperhidrosis Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Axillary Hyperhidrosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Axillary Hyperhidrosis Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Axillary Hyperhidrosis Drug Market
Table 35. Key Manufacturers Axillary Hyperhidrosis Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Axillary Hyperhidrosis Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Axillary Hyperhidrosis Drug Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Axillary Hyperhidrosis Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Axillary Hyperhidrosis Drug Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Axillary Hyperhidrosis Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Axillary Hyperhidrosis Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Axillary Hyperhidrosis Drug Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Axillary Hyperhidrosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Axillary Hyperhidrosis Drug Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Axillary Hyperhidrosis Drug Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Axillary Hyperhidrosis Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Axillary Hyperhidrosis Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Axillary Hyperhidrosis Drug Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Axillary Hyperhidrosis Drug Sales by Application (2018-2024) (K Pcs)
Table 60. North America Axillary Hyperhidrosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Axillary Hyperhidrosis Drug Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Axillary Hyperhidrosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Axillary Hyperhidrosis Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Axillary Hyperhidrosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Axillary Hyperhidrosis Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Allergan Plc Company Information
Table 110. Allergan Plc Introduction and Business Overview
Table 111. Allergan Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Allergan Plc Axillary Hyperhidrosis Drug Product
Table 113. Allergan Plc Recent Development
Table 114. Brickell Biotech Inc Company Information
Table 115. Brickell Biotech Inc Introduction and Business Overview
Table 116. Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Brickell Biotech Inc Axillary Hyperhidrosis Drug Product
Table 118. Brickell Biotech Inc Recent Development
Table 119. Dermira Inc Company Information
Table 120. Dermira Inc Introduction and Business Overview
Table 121. Dermira Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Dermira Inc Axillary Hyperhidrosis Drug Product
Table 123. Dermira Inc Recent Development
Table 124. Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
Table 125. Dr. August Wolff GmbH & Co KG Arzneimittle Introduction and Business Overview
Table 126. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product
Table 128. Dr. August Wolff GmbH & Co KG Arzneimittle Recent Development
Table 129. GlaxoSmithKline Plc Company Information
Table 130. GlaxoSmithKline Plc Introduction and Business Overview
Table 131. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product
Table 133. GlaxoSmithKline Plc Recent Development
Table 134. TheraVida Inc Company Information
Table 135. TheraVida Inc Introduction and Business Overview
Table 136. TheraVida Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. TheraVida Inc Axillary Hyperhidrosis Drug Product
Table 138. TheraVida Inc Recent Development
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Axillary Hyperhidrosis Drug Market Trends
Table 142. Axillary Hyperhidrosis Drug Market Drivers
Table 143. Axillary Hyperhidrosis Drug Market Challenges
Table 144. Axillary Hyperhidrosis Drug Market Restraints
Table 145. Axillary Hyperhidrosis Drug Distributors List
Table 146. Axillary Hyperhidrosis Drug Downstream Customers
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Axillary Hyperhidrosis Drug Product Picture
Figure 2. Global Axillary Hyperhidrosis Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Axillary Hyperhidrosis Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Axillary Hyperhidrosis Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Botulinum ToxinA
Figure 6. Global Botulinum ToxinA Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Glycopyrrolate
Figure 8. Global Glycopyrrolate Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Glycopyrronium Tosylate
Figure 10. Global Glycopyrronium Tosylate Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Axillary Hyperhidrosis Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Axillary Hyperhidrosis Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Axillary Hyperhidrosis Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Axillary Hyperhidrosis Drug Revenue in 2022
Figure 27. Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Home Care
Figure 33. Global Home Care Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Axillary Hyperhidrosis Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Axillary Hyperhidrosis Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Axillary Hyperhidrosis Drug Manufacturing Cost Structure
Figure 47. Axillary Hyperhidrosis Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries